Quantum-Si (NASDAQ:QSI) Given Buy Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Quantum-Si (NASDAQ:QSI) in a report issued on Wednesday morning,Benzinga reports. The firm currently has a $4.00 price objective on the stock.

Separately, Canaccord Genuity Group lowered their price objective on Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday.

Quantum-Si Stock Up 2.1 %

Shares of Quantum-Si stock opened at $0.79 on Wednesday. The company has a market cap of $112.65 million, a PE ratio of -1.24 and a beta of 2.89. Quantum-Si has a 52 week low of $0.70 and a 52 week high of $2.43. The business has a 50 day moving average price of $0.86 and a 200-day moving average price of $1.12.

Quantum-Si (NASDAQ:QSI) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.21) by $0.03. The firm had revenue of $0.79 million during the quarter, compared to the consensus estimate of $1.06 million. Quantum-Si had a negative return on equity of 35.42% and a negative net margin of 3,968.84%. As a group, research analysts anticipate that Quantum-Si will post -0.71 EPS for the current year.

Institutional Trading of Quantum-Si

A number of institutional investors and hedge funds have recently modified their holdings of QSI. XTX Topco Ltd purchased a new stake in shares of Quantum-Si during the second quarter valued at approximately $25,000. Public Employees Retirement System of Ohio purchased a new stake in shares of Quantum-Si during the first quarter valued at approximately $27,000. Bleakley Financial Group LLC bought a new position in Quantum-Si during the first quarter valued at $28,000. SG Americas Securities LLC bought a new position in Quantum-Si during the third quarter valued at $53,000. Finally, Virtu Financial LLC bought a new position in Quantum-Si during the first quarter valued at $98,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

About Quantum-Si

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.